- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: programmed cell death protein 1 (PD-1)
Total 105394 results
-
Ascletis Pharmaceuticals Co., Ltd.RecruitingHIV Infections | HIV-1-infection | PD-L1 Gene MutationChina
-
Sun Yat-sen UniversityRecruitingPD-1 Inhibitor | Granulocyte Colony-Stimulating FactorChina
-
Third Affiliated Hospital, Sun Yat-Sen UniversityRecruitingHepatocellular CarcinomaChina
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
NYU Langone HealthBristol-Myers SquibbCompleted
-
Thomas MarronRecruiting
-
Dalian UniversityUnknownNon-small Cell Lung Cancer
-
NYU Langone HealthEMD SeronoCompleted
-
Merck Sharp & Dohme LLCCompletedSmall Cell Lung Cancer (SCLC)United States, Australia, Canada, Chile, France, Germany, Hungary, Ireland, Israel, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Switzerland, Taiwan, Turkey, United Kingdom
-
Centre Leon BerardNETRIS PharmaRecruitingAdvanced Solid Tumors | Metastatic Solid TumorsFrance
-
Merck Sharp & Dohme LLCCompleted
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central HospitalWithdrawnHepatocellular CarcinomaChina
-
Genentech, Inc.Completed
-
Merck Sharp & Dohme LLCGOG Foundation; European Network of Gynaecological Oncological Trial Groups...Active, not recruitingUterine Cervical NeoplasmsCanada, United States, Australia, Austria, Belgium, Brazil, Chile, China, Colombia, Czechia, France, Germany, Greece, Guatemala, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Norway, Peru, Russian Federation, Spain, Sweden, ... and more
-
Academic Thoracic Oncology Medical Investigators...AstraZenecaCompletedNon-Small Cell Lung Cancer NSCLCUnited States
-
Istari Oncology, Inc.Active, not recruiting
-
Hasan Kalyoncu UniversityRecruiting
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
Shandong Cancer Hospital and InstituteJiangsu HengRui Medicine Co., Ltd.RecruitingTriple Negative Breast CancerChina
-
University of ChicagoWithdrawnHead and Neck CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingSolid Tumor | Endometrial Cancer | Cutaneous Squamous Cell CarcinomaCanada, Australia, Taiwan, Malaysia, United States, Netherlands, Turkey, France
-
Zhongnan HospitalRecruitingHepatocellular Carcinoma; Targeted Therapy; Progression-free SurvivalChina
-
University Hospital HeidelbergDepartment of Dermatology, Heidelberg University HospitalCompletedMelanoma | Exercise | PD-1 AntibodiesGermany
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced Hepatocellular CarcinomaUnited States, China, Italy, Japan, Korea, Republic of, Poland, Spain, Switzerland, Taiwan
-
Guoxin LiNot yet recruiting
-
IO BiotechMerck Sharp & Dohme LLCCompletedNSCLCUnited Kingdom, Germany, Netherlands, Spain
-
Dong WangNot yet recruiting
-
Fudan UniversityNot yet recruitingGastric Cancer | MSI-H | Adjuvant Therapy | PD-1 ImmunotherapyChina
-
Changhai HospitalNot yet recruitingHER-2 Protein Overexpression | Esophageal Squamous Carcinoma
-
Cancer Institute and Hospital, Chinese Academy...RecruitingLocally Advanced Non-Small Cell Lung CancerChina
-
Sohag UniversityNot yet recruitingAcute Lymphoblastic Leukemia in PediatricEgypt
-
Yongchang ZhangRecruitingHER2 Insertion Mutation Positive Advanced NSCLCChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedLung Diseases | Neoplasms by Site | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Respiratory Tract Disease | Neoplasm, BronchialChina
-
University of LiegeUnknown
-
EZUS-LYON 1Active, not recruiting
-
EZUS-LYON 1Active, not recruitingElderly | Gait | Balance, PosturalFrance
-
Adanate, IncRecruiting
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompleted
-
John KirkwoodBristol-Myers Squibb; Secura Bio, Inc.RecruitingUnresectable MelanomaUnited States
-
Shenzhen Geno-Immune Medical InstituteRecruitingSarcoma | Ewing Sarcoma | Osteoid SarcomaChina
-
Xuanwu Hospital, BeijingUnknownNon-small Cell Lung Cancer | PD-1 Antibody | Lung Cancer Stage II
-
The Affiliated Hospital of Qingdao UniversityUnknownNSCLC Stage IV | PD-1 | ARID1AChina
-
Merck Sharp & Dohme LLCRecruitingMelanoma | Lymphoma | Solid Tumor | Classical Hodgkin Lymphoma | Microsatellite-instability-high Solid TumorFrance, Germany, Italy, Netherlands, Sweden, United Kingdom, Brazil, Israel, Korea, Republic of, United States
-
Merck Sharp & Dohme LLCCompletedHead and Neck Squamous Cell Cancer
-
Fudan UniversityRecruiting
-
Henlix, IncUnknown
-
RenJi HospitalRecruitingFumarate Hydratase Deficient Renal Cell CarcinomaChina
-
Diwakar DavarMerck Sharp & Dohme LLCActive, not recruitingSquamous Cell CarcinomaUnited States
-
The Affiliated Hospital of Qingdao UniversityUnknown